Abstract The contractile activation of the upper (dome) and lower (base) parts of the urinary bladder show some differences. Cellular mechanisms that might be responsible for cholinergic effects blocking non-adrenergic non-cholinergic contractions in the base of the rat urinary bladder were investigated. Smooth muscle cells were thus freshly isolated or cultured both from the dome and the base of the rat urinary bladder and the contribution from cholinergic and purinergic pathways to their Ca 2? homeostasis was examined. The expression of nicotinic acetylcholine (nAChR) and P2X2 purinergic receptors on the cultured cells and on tissue sections was investigated. The ATPevoked Ca 2? transients in rat smooth muscle cells did not show any desensitization. However, when ATP was administered together with carbamylcholine (CCh), the latter essentially prevented ATP from evoking Ca 2? transients in smooth muscle cells from the base (suppression to 12 ± 2.5% of control, n = 57; p \ 0.01), but not from the dome (99 ± 5% of control, n = 52; p [ 0.05) of the rat urinary bladder. While atropine was unable to modify (6 ± 3% of control, n = 14; p \ 0.05), a-bungarotoxin (118 ± 12% of control, n = 20; p [ 0.05) blocked the inhibitory effects of CCh. Additionally, a7 subunits of nAChR and P2X2 purinergic receptors were identified using immunocytochemistry, immunohistochemistry, and Western blot in cultured urinary bladder smooth muscle cells, in urinary bladder sections, and in urinary bladder muscle strips, respectively, suggesting that the activation of nAChR modifies the action of ATP.
Introduction
The functions of the urinary bladder are to relax and store urine during filling, and to contract complementing urethral processes to empty the bladder during micturition. These roles are achieved through complex interactions between the autonomic nervous system and the urinary bladder, primarily the smooth muscle cells. Urinary bladder smooth muscle in adult rats is well innervated (Gabella 1999) . The bundles of nerve fibres branch repeatedly in urinary bladder smooth muscle and eventually become single fibres containing varicosities. The varicosities contain neurotransmitters, including acetylcholine (ACh) and adenosine triphosphate (ATP) (Gabella 1995) .
During electrical stimulation of the parasympathic nerves ACh and ATP are co-released from the nerve terminals to stimulate the muscarinic and purinergic receptors of the smooth muscle cells, respectively, and to elicit bladder contraction (Dowdall et al. 1974; Kasakov and Burnstock 1982; Theobald and de Groat 1989) . Acetylcholine is a ubiquitous transmitter, while ATP plays an additional role in many species, including rats (Calvert et al. 2001; Somogyi et al. 2002; Szigeti et al. 2005) . Acetylcholine acts via M 3 receptor activation, generation of intracellular inositol-1,4,5-trisphosphate (IP 3 ) and Ca 2? release from intracellular stores. There is also evidence that muscarinic activation leads to Ca 2? influx (Schneider et al. 2004) . Conversely, ATP binds to ionotropic P2X receptors, depolarizing the cell membrane and instigating Ca 2? influx through voltage-activated (mainly L-type) Ca 2? channels (Andersson and Arner 2004 (Andersson and Arner 2004; Arner et al. 2007) .
Transient increases in [Ca 2? ] i in smooth muscle have been recorded following the activation of purinergic receptors. In urinary bladder smooth muscle, the activation of purinergic receptors may induce excitatory junctional potentials and Ca 2? transients (Bramich and Brading 1996; Hashitani et al. 2000) . Field stimulation of the smooth muscle evoked local, transient Ca 2? release events. These events were mediated by postsynaptic smooth muscle P2X receptors activated by ATP released from synaptic varicosities (Brain et al. 2002 (Brain et al. , 2003 . Pharmacological studies also confirmed that junctional Ca 2? transients were mediated through the activation of purinergic receptors (Lamont and Wier 2002; Lamont et al. 2003) .
Ligand-gated receptors may interact and regulate one other both at the neuronal and the end-organ levels and modulate their responses to external stimuli . G-protein coupled metabotropic receptors commonly ''cross-talk'' through intracellular second messenger molecules and protein phosphorylation (de Blasi et al. 2001; Moldrich and Beart 2003) . Recently, ionotropic receptors have also been shown to interact directly with one another in ganglia. Co-activation of the nicotinic and the P2X 2 purinergic receptors inhibited the functions of both ion-channel receptors through direct protein-protein interaction on the neuronal cell membrane (Nakazawa 1994; Zhou and Galligan 1998; Barajas-Lopez et al. 1998; Khakh et al. 2000 Khakh et al. , 2005 . Negative interactions between the nicotinic and 5-HT 3 receptors (Barajas-Lopez et al. 2002; Boue-Grabot et al. 2003) and between the GABA A and P2X purinergic receptors (Sokolova et al. 2001) have also been described when the two ionotropic receptors were co-activated in neurons. However, similar interaction between nicotinic and purinergic receptors at the bladder smooth muscle level has not been described on cellular but suggested at tissue level (Lai et al. 2008 ).
Here we investigated the cholinergic and purinergic contribution to the Ca 2? homeostasis of smooth muscle cells isolated from young adult rat urinary bladders. Given the potential role for nicotinic acetylcholine receptors (nAChRs) in the neural control of bladder function, the current study was aimed to determine whether nAChRs are also expressed in the smooth muscle cells and whether activation of these receptors can alter the function of these cells. We present evidence for the existence and determine its location dependence of the interaction between the purinergic and cholinergic signaling in smooth muscle cells of the urinary bladder. Certain aspects of these results were presented at the Annual Conference of the European Muscle Society (Jenes et al. 2006; Szigeti et al. 2007 ).
Materials and methods
All experiments were performed in accordance with Hungarian guidelines and were in compliance with the ''European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes' ' (Council of Europe No 123, Strasbourg 1985) .
Smooth muscle cell culture from rat urinary bladder Young adult Wistar rats (male and female, 8-12 weeks old) were terminally anaesthetized by isoflurane, bladders were removed, opened and cut into a base and a dome part. The pieces were placed into Hank's solution and the mucosal layer was removed. Each smooth muscle piece was placed into 5 ml 0.75 mg ml -1 trypsin (SigmaAldrich, Heidelberg, Germany)-0.4 mg ml -1 EDTA (Sigma-Aldrich, Heidelberg, Germany) solution, and incubated in a shaking bath for 30 min at 37°C. After transferring into RPMI 1640 (Roswell Park Memorial Institute) solution containing 0.75 mg ml -1 collagenase (Sigma-Aldrich, Heidelberg, Germany) the smooth muscle was cut into small pieces and incubated in shaking bath for further 45 min at 37°C. After incubation 2 ml fetal bovine serum (FBS) was added, cells were centrifuged at 1000 RPM for 10 min, then the superfusate containing collagenase was removed. Cells were resuspended in 3 ml RPMI solution containing 10% FBS and centrifuged again at 1000 RPM for 10 min (twice). After the last cleaning process 3 ml RPMI solution containing 10% FBS was added for 3 plates (diameter 3 cm) having 1 ml cell suspension each. This medium was renewed every second day until the cells reached a confluence of 60-70%. At that point, the FBS content of the RPMI medium was reduced to 1% for 2-3 more days to facilitate myocyte differentiation. Experiments were carried out on 5-7-days-old cultures.
The smooth muscle cells in the cultures were morphologically distinct from the interstitial cells and their identity was confirmed with immunocytochemistry using primary antibodies against alpha smooth muscle actin.
Freshly isolated smooth muscle cells from rat urinary bladder Same method was used as for the cell culture, but the isolated cells were tested right after they attached to the coverslips. All of these experiments were carried out within 20 h after removing the urinary bladder from the rats.
Changes in the concentration of [Ca 2? ] i were detected using the fluorescent dye Fura-2 as described in our previous reports (Bíró et al. 1998; Csernoch et al. 2000) . To introduce the calcium-sensitive probe into the intracellular space cells were incubated for 90 min at 37°C with 15 lM Fura-2 AM (Molecular Probes, Eugene, OR, USA). Coverslips were then washed with normal HEPES Tyrode's solution (in mM: 137 NaCl, 5.4 KCl, 0.5 MgCl 2 , 1.8 CaCl 2 , 11.8 HEPESNaOH, 1 g l -1 glucose, pH 7.4) and this solution also provided the extracellular environment for the cells throughout the entire measurement. The coverslips with the Fura-2 loaded cells were then placed on the stage of an inverted fluorescence microscope (Diaphot, Nikon, Japan). The measuring bath was constantly perfused with normal HEPES Tyrode's solution at a 2 ml min -1 rate (Econo Pump, BioRad Hungary, Budapest, Hungary). Test solutions were directly applied to the cells through a local perfusion capillary (Perfusion Pencil TM , AutoMate Scientific, San Francisco, CA, USA) with an internal diameter of 250 lm at a 1.5 ll s -1 rate, using a local perfusion system (Valve Bank TM 8 version 2.0, AutoMate Scientific, San Francisco, CA, USA). Experiments were performed at room temperature (22-24°C). Excitation wavelength was altered between 340 and 380 nm by a dual-wavelength monochromator and an on-line connected microcomputer (Deltascan, Photon Technology International, New Brunswick, NJ, USA) while the emission was monitored at 510 nm using a photomultiplier at an acquisition rate of 10 Hz per ratio. Background fluorescence was measured at cell-free regions of the coverslip and subtracted automatically.
[Ca 2? ] i levels were calculated according to the method of Grynkiewicz et al. (1985) from the ratio (R = F 340 /F 380 ) of the fluorescence intensities measured with excitation wavelengths 340 nm (F 340 ) and 380 nm (F 380 ) as previously described (Bíró et al. 1998; Csernoch et al. 2000) using in vivo calibration data.
Immunocytochemistry
Smooth muscle cells from urinary bladders were cultured on sterile plates. The 5-7 days old cells were fixed in acetone for 5 min and then permeabilized by 0.1% Triton-X-100 (Sigma-Aldrich, Heidelberg, Germany) in a phosphate buffered saline (PBS, 0.02 M NaH 2 PO 4 , 0.1 M NaCl) for 10 min. After washing with PBS solution and blocking with 1% bovine serum albumin (BSA, Sigma-Aldrich, Heidelberg, Germany) in PBS for 30 min, cells were incubated with anti-nAChRa7 primary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or anti-P2X 2 receptor primary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4°C (dilution 1:50, 1:200, 1:500). Plates were washed three times in PBS then incubated with fluoresceine isothiocyanate (FITC) conjugated secondary antibodies (Vector Laboratories, Burlingame, CA, USA) for 45 min (dilution 1:200). The nuclei of cells were visualised using 4 0 ,6-diamidino-2-phenylindole (DAPI). Cells were examined on a confocal microscope (Zeiss LSM 510 META, Zeiss, Oberkochen, Germany).
Immunohistochemistry
The tissue specimens were immediately fixed in 4% buffered formaldehyde (24 h), embedded in paraffin wax, and 4 lm thick sections were cut. The endogenous peroxidase activity was blocked with 3% H 2 O 2 in methanol (10 min, room temperature). Non-specific binding was prevented by incubating the sections with BSA. The tissue sections were then incubated overnight at 4°C with anti-nAChRa7-specific primary antibodies (dilution 1:200, Santa Cruz Biotechnology). After incubation, the slices were rinsed three times with PBS for 5 min. The sections were incubated in biotinylated anti-goat secondary antibodies (raised in rabbit) for 30 min (1:100, Dako, Glostrup, Denmark), then rinsed with PBS and incubated with horseradish peroxidase-conjugated streptavidin (30 min; 1:500; room temperature). In these instances visualisation of the immunolabelling was also achieved using 3,3 0 -diaminobenzidine (DAB). At the end of the procedure slight counterstaining was performed using hematoxylin. Control experiments were regularly performed. In these cases, the sections were incubated overnight without the primary antibody.
Western blot
To determine the expression of nAChRa7 subunits in different parts of the young adult rat bladder, Western blot technique was applied. Tissues were homogenized in homogenization buffer [20 mM Tris-Cl, pH 7.4, 5 mM EGTA, 1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride, 20 lM leupeptin, all from Sigma] and the protein content of samples was measured by a modified bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL, USA). The samples were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (8% gels were loaded with 20-30 lg protein per lane), transferred to nitrocellulose membranes (Bio-Rad, Vienna, Austria), and then probed with the above mentioned anti-nAChRa7 antibodies (1:100). A horseradish peroxidase-conjugated rabbit anti-goat IgG antibody (1:500, Bio-Rad) was used as a secondary antibody, and the immunoreactive bands were visualized by enhanced chemiluminescence (Gel Logic 1500 Imaging System, Carestream, Rochester, NY, USA). Western blotting experiments were repeated five separate times, and the protein bands were analyzed by Image J software provided by the NIH. The densitometric values were normalized to the values of actin immunoreactivity to correct any loading and transfer differences between samples.
Data analysis
Data were analyzed using Microsoft Excel Ò (Microsoft, Redmond, WA, USA) and Microcal Origin Ò (OriginLab, MA, USA) computer softwares. Data are expressed as mean ± SEM. Student's t-test was used to compare paired data between the control group (first ATP application) and the other groups (purinergic and cholinergic agonists and antagonists), and 2-tailed p \ 0.05 was taken to indicate statistical significance.
Results

Effect of repetitive ATP application on the Ca 2?
transients of cultured smooth muscle cells from the urinary bladder To study the role of the purinergic and cholinergic stimulation, first the shape and reproducibility of the ATPinduced Ca 2? transients were determined on cultured rat urinary bladder smooth muscle cells (Fig. 1) . ATP (180 lM) was applied for 40 s three times (at time zero, then three and six minutes later) to activate P2 receptors and induce Ca 2? transients. There were no visible changes in the second and third Ca 2? transients as compared to the first one (Fig. 1a) . To quantify any possible changes that might have occurred, single exponential functions were fitted to the declining phase of the calcium transients and their time constant (s) was determined. In addition, the peak of the first time derivative of the signal was used to assess its maximal rate-of-rise. Pooled data from 7 independent experiments (7 cells from 7 animals) confirmed that the amplitude (Fig. 1b) , the s (Fig. 1c) and the maximal rate-of-rise (Fig. 1d) of the second and third transients were not significantly different statistically (p [ 0.05) from those of the first transient.
Interaction between purinergic and cholinergic pathways at the level of the Ca 2? transients on freshly isolated and cultured smooth muscle cells
To understand the possible cross-reactivity between the purinergic and cholinergic signaling pathways, cultured and freshly isolated smooth muscle cells from adult rat urinary bladders were stimulated by the agonists of the two pathways (Fig. 2) . While ATP was essentially always (more than 90% of the cells) capable of initiating a calcium transient, the parasympathetic agonists carbamylcholine (carbachol; CCh) and nicotine (nic) could not induce elevations in [Ca 2? ] i in rat smooth muscle cells, either cultured (n = 109) or freshly isolated (n = 5). 
However, when ATP was administered together with 10 lM CCh, CCh prevented ATP from evoking Ca 2? transients in the rat smooth muscle cell from the base of the urinary bladder (Fig. 2b, c) . All together 57 cultured (Fig. 2b ) and 3 freshly isolated (Fig. 2c) cells from the base of the urinary bladder prepared from 18 and 3, respectively animals were tested. While CCh decreased the amplitude of the ATP-evoked Ca 2? transients by 88 ± 2.5% (p \ 0.01), this cross-inhibition was not present when ATP was applied together with 5 lM nicotine (Fig. 2) . The effect of nicotine was tested on 20 cells obtained from 6 animals. On the other hand, neither carbachol nor nicotine inhibited the effect of ATP in the cells of the dome of the urinary bladder (52 cells prepared from 16 rats, Fig. 2a ).
Pharmacological characterization of the cross-inhibition
To establish the cholinergic receptor subtype responsible for the observed cross-inhibition in the cells of the base of the urinary bladders, muscarinic and nicotinic antagonists were applied (Fig. 3) . The muscarinic receptor blocker atropine (1 lM; Fig. 3a, b ) was unable to modify the purinergiccholinergic interactions (24 cells from 4 animals). That is, on the one hand, when the cross-inhibition was present for ATP and CCh-on cells from the base-, the co-application of atropine with ATP and CCh could not prevent the purinergiccholinergic inhibition (Fig. 3a, 4) . On the other hand, when there was no interaction between the purinergic and cholinergic pathways without atropine-on cells from the dome-, there was no interaction between them in the presence of atropine either (Fig. 3b, 4) .
In contrast, the presence of a-bungarotoxin-a specific competitive antagonist of the nicotinic acetylcholine receptor (nAChR)-prevented carbachol from interfering with the ATP-evoked calcium transients (Fig. 3c, d, 4) . In 20 cells from three animals isolated from the base of urinary bladders CCh was unable to block the effect of ATP when a-bungarotoxin (500 nM) was present in the bathing medium (Fig. 3c, 4) . Nevertheless, a-bungarotoxin did not interfere with the ATP-evoked signals since the simultaneous presence of CCh and the toxin did not modify the calcium transients in the cells isolated from the dome (Fig. 4d) . The pooled data (Fig. 4) confirmed that while the effect of a-bungarotoxin was statistically significant (p \ 0.05) in cells from the base, the toxin did not modify significantly (p [ 0.05) the changes in [Ca 2? ] i in cells from the dome.
To narrow the possible receptor candidates for the purinergic pathway different purinergic agonists were also tested. From the P2X receptor agonists neither a,b-methylene-ATP (10 lM; cultures from 6 animals, data from 25 (Fig. 5a ). In this respect, there were no significant differences between the cells isolated from the base and the dome. In addition, the P2Y receptor agonist UTP (180 lM; cultures from 5 animals, data from 29 cells, 20 cells from the base and 9 cells from the dome) could not induce Ca 2? transients in cultured smooth muscle cells of the urinary bladder (Fig. 5b) . Again, there were no significant differences, in this respect, between the cells from the base and the dome. In addition, the L-type calcium channel blocker nifedipine (10 lM) significantly-to 38 ± 15% of the response measured in the absence of nifedipine (p \ 0.05; 9 cells from 2 animals)-reduced the ATP-induced Ca 2? transients (data not shown). Noteworthy, that CCh was still able to further reduce the effect of ATP in the presence of nifedipine (to 0%; 2 cells from 1 animal).
Immunostaining of the nicotinic receptors and P2X 2 receptors in smooth muscle cell cultures and urinary bladder tissue sections CCh can serve as an agonist for the a 1 , a 3 , a 4 , a 7 , and a 9 nAChR subunits and, furthermore, it has a higher affinity than nicotine does towards the a 1 , a 7 , and a 9 subunits (Alexander et al. 2008) . This, together with the effects seen with a-bungarotoxin (see above) led us to suspect the involvement of the a 7 subunit of nAChR in the cross-inhibition detail before. To determine the distribution of the a subunit of the nicotinic receptors, cultured smooth muscle cells from rat urinary bladders (Fig. 6a ) and bladder tissue sections (Fig. 6b) were used. Cultured smooth muscle cells from the rat urinary bladder, both from the base and from the dome, displayed a7 nicotinic receptor positivity, however, it seemed to be more intensive for cells from the base than that of the cells from the dome (Fig. 6a) . The a7 nicotinic receptor immunoreactions in urinary bladder tissue sections showed similar distribution (Fig. 6b) . Western-blot analysis confirmed the expression of nAChRa7 protein in rat urinary bladder smooth muscle strips (Fig. 6c) . Furthermore, quantitative evaluation of the Western blots (normalizing the absorbance of the nAChRa7 band to that of the actin band) confirmed that the expression of nAChRa7 in the cells from the base was significantly higher than the expression in the cells from the dome (Fig. 6d, p \ 0.05) .
Based on previous reports (Creed et al. 2010; Dutton et al. 1999; Lee et al. 2000; Studeny et al. 2005 ) and the pharmacological profile of the ATP-evoked calcium transients presented above, we suspected the presence of P2X 2 receptors in the rat urinary bladder smooth muscle. This was indeed confirmed on our cultures using immunocytochemical surveys (Fig. 7) . Distribution of the P2X 2 receptors appears to be more cytoplasmic than membrane, in agreement with previous studies. Fig. 3 Pharmacological characterization of the crossinhibition. The muscarinic acetylcholine receptor blocker atropine (1 lM) was unable to modify the purinergiccholinergic interactions (a, smooth muscle cell from the base; b, smooth muscle cell from the dome of the bladder). The nicotinic acetylcholine receptor blocker a-bungarotoxin did not interfere with the ATPevoked signals in the cells isolated from the dome (d, 500 nM), but it prevented carbachol from inhibiting the ATP-evoked calcium transients in the cells isolated from the base (c, 500 nM)
Discussion
This report presents evidence of purinergic (P2X) and cholinergic (nAChR) receptor cross-inhibition in nonneural cells. The cross-inhibition between the two signaling pathways was observed in the base, but not in the dome of the rat urinary bladder. We, on the one hand, demonstrated the contribution of the purinergic signaling pathway to the Ca 2? homeostasis in cultured rat smooth muscle cells as ATP was able to evoke Ca 2? transients in the smooth muscle cells and these transients did not show any desensitization. On the other hand, when ATP was administered together with the parasympathetic agonist carbachol, the latter prevented ATP from evoking Ca 2? transients in the cells from the base of the urinary bladder. Since a-bungarotoxin but not atropine was able to interfere with this interaction and because certain nicotinic receptors are also sensitive to CCh, we suspected the presence of the nAChRa7 on our cells. Smooth muscle cells from the rat urinary bladder-either isolated or in situ-displayed a7 nicotinic receptor positivity. Furthermore, cells from the base of the bladder seemed to have stronger immunopositivity than the cells from the dome as confirmed by Western blotting. Noteworthy, however, that-unlike in muscle strips from urinary bladders-CCh was unable to activate isolated or cultured smooth muscle cells.
Cholinergic and purinergic receptor activation in cultured smooth muscle cells from the urinary bladder Our results suggest a unique interaction between P2X purinergic and a putative nicotinic receptor in the bladder smooth muscle. Earlier measurements gave evidence on cholinergic (nicotinic) and purinergic interaction between neuronal type nicotinic and P2X 2 purinergic receptors in rat sympathetic ganglia (Nakazawa 1994) , hippocampal neurons (Khakh et al. 2005) , autonomic ganglia , and myenteric neurons (Barajas-Lopez et al. 1998; Zhou and Galligan 1998; Brown and Galligan 2003) . In these systems, co-application of a nicotinic agonist (nicotine, cystine) and a purinergic agonist (ATP, a,bmethyleneATP) produced lower additive response (inward currents, calcium influx) then what was expected from independent receptor stimulations.
The question then was, whether there are nicotinic receptors present on urinary bladder smooth muscle cells. Traditionally smooth muscle is not considered to be equipped with nicotinic receptors (Jensen et al. 2005) . It is important to note that even if nicotinic receptors are present in the bladder smooth muscle, they are silent since nicotinic agonists do not elicit a contraction and no intramural ganglia can be found in rat bladders (Alian and Gabella 1996; Somogyi and de Groat 1992) . However, expression of several isoforms of the nicotinic receptor has been demonstrated in vascular smooth muscle (Brüggmann et al. 2002) . Nicotinic receptors are also found in the urothelium in urinary bladder (Beckel et al. 2006; Birder and de Groat 2007) . Our study provides evidence that while nicotinic receptors are present on the bladder smooth muscle cells, too, their activation is indeed not accompanied by an elevation in intracellular Ca 2? concentration. The current study, nevertheless, demonstrated that nicotinic receptors on the smooth muscle may play an important role in modulating the activity of the purinergic signal transduction.
There is no doubt, that carbachol activates both intracellular calcium release and contraction of urinary bladder smooth muscle strips (Munro and Wendt 1994; Waring and Wendt 2000; Rivera and Brading 2006) . Therefore, the inability of carbachol to induce an elevation in [Ca 2? ] i when isolated smooth muscle cells were tested was unexpected. Most of the experiments presented in this study were carried out on cells held in primary culture. Due to the fact that culturing could lead to alterations in muscarinic receptor expression pattern or in the signalling pathways (Hsieh and Farley 2002; Boselli et al. 2002) , we carried out similar experiments on freshly isolated cells, too. Since these cells responded similarly in all aspects-while carbachol was unable to generate Ca 2? transients it interfered with ATP in evoking an increase in [Ca 2? ] i -we can conclude that the observations were not exclusively due to culturing. We can only speculate that the isolation itself and the consequent changes in the extracellular environment (loss of neurons, Cajal cells, mediators) modify the cholinergic signalling, not the culturing conditions. It has been hypothesised that M2 muscarinic receptor expression in human detrusor muscle is sensitive to trophic or environmental factors, which sustain the receptor presence in the tissue but not in cultured cells (Boselli et al. 2002) , similarly how nerve growth factor, platelet-derived growth factor and extracellular regulated kinases affect M2 receptor expression in primary fetal striatal cultures (Ebstein et al. 1993) or in HEL 299 cells (Rousell et al. 1997 ). This discrepancy between isolated cells and muscle strips may rise the question if there was a physiological relevance of the observed cross-inhibition between the cholinergic and purinergic system. We could not know if the cross-inhibition does or does not occur in vivo, but the main participants in this interaction are most probably nicotinic acethylcholine receptors and P2X 2 purinergic receptors, so the presence/absence of muscarinic receptors should not influence the cross-inhibition fundamentally.
The possible receptor subtype candidates for the cholinergic-purinergic receptor interaction Based on our data on the pharmacology of the urinary bladder smooth muscle cells we suggest that the P2X 2 receptors have importance in this cholinergic-purinergic interaction. The P2 receptors displayed no or just a slow and partial desensitization. They were not activated by the application of a,b-methylene-ATP, 2-methyl-thio-ATP (data not shown) and UTP, consistent with the idea that ATP-induced Ca 2? transients are generated via activating P2X 2 receptors in the cultured urinary bladder smooth muscle cells. The presence of P2X 2 receptors on these cells has already been described (Creed et al. 2010; Dutton et al. 1999; Lee et al. 2000; Studeny et al. 2005 ) and were also detected through immunostaining in this study.
In our experiments the muscarinic receptor blocker atropine did not modify the purinergic-cholinergic interactions. When we found cross-inhibition applying ATP and CCh together, atropine could not prevent this interaction, in addition, when such interaction was not observed, atropine did not invoke such interaction either. These data suggest that muscarinic acethylcholine receptors do not have any role in the purinergic-cholinergic receptor cross-inhibition. On the other hand, the presence of a-bungarotoxin prevented CCh from interfering with the purinergic signaling pathway on cells from the base but had no effect on cells from the dome. Since a-bungarotoxin is considered as a specific antagonist for nAChR, especially for the a7 subunit (Couturier et al. 1990; Kempsill et al. 1999) , we must assume a role of the nicotinic receptors instead. Our immunocyto-and immunohistochemistry, as well as Westernblot data confirmed the presence of nAChRa7 positive smooth muscle cells in cultures and in urinary bladder tissues from rat. It should be noted, however, that the muscarinic agonist carbachol had modulatory effect on the nicotinic acethylcholine receptors, while nicotine itself did not affect the inhibitory function of these receptors. The findings that a 1 , a 3 , a 4 , a 7 , and a 9 nAChRs can be activated by carbachol (Alexander et al. 2008) , moreover, the affinity of the a 1 , a 7 , and a 9 subunits to carbachol is higher than that to nicotine may explain our results. We have to mention though, that we therefore tested the effects of higher concentrations of nicotine (up to 10 lM) and still did not see any inhibitory effect. Although we cannot exclude the possibility that even higher concentrations would have had an effect, this was not investigated. 
